Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim L Jansen

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
Clinical Rheumatology|June 15, 2016
Discrepancies in how the impact of gout is assessed in outcomes research compared to how health professionals view the impact of gout, using the lens of the International Classification of Functioning, Health and Disability (ICF)Eveline M Kool, Marieke J Nijsten, Annelies E van Ede, et al.
Deutsches Arzteblatt International|October 2, 2009
Gout--current diagnosis and treatmentAnne-Kathrin Tausche, Tim L Jansen, Hans-Egbert Schröder, et al.
Rheumatology (Oxford, England)|September 2, 2024
An objective diagnosis of gout and calcium pyrophosphate deposition disease with machine learning of Raman spectra acquired in a point-of-care settingTom Niessink, Tim L Jansen, Frank A W Coumans, et al.
The Lancet. Rheumatology|June 19, 2026
Gout treat-to-target for whom? - Authors' replyAnusha Moses, Martijn A H Oude Voshaar, Mart A F J van de Laar, et al.
Arthritis Care & Research|April 15, 2024
Diagnostic Accuracy of Raman Spectroscopy Integrated With Polarized Light Microscopy for Calcium Pyrophosphate-Associated ArthritisTom Niessink, Matthijs Janssen, Tanja Giesen, et al.
Expert Opinion on Drug Safety|March 16, 2011
The potential risk of infections during (prolonged) rituximab therapy in rheumatoid arthritisIthamar Heber Brinkman, Mart A F J van de Laar, Tim L Jansen, et al.
Rheumatology and Therapy|February 16, 2019
Reassessing the Safety Profile of Lesinurad in Combination with Xanthine Oxidase Inhibitor TherapyFernando Perez-Ruiz, Tim L Jansen, Anne-Kathrin Tausche, et al.
Annals of the Rheumatic Diseases|August 7, 2012
Gout: why is this curable disease so seldom cured?Michael Doherty, Tim L Jansen, George Nuki, et al.
Annals of the Rheumatic Diseases|June 12, 2014
Imaging modalities for the classification of gout: systematic literature review and meta-analysisAlexis Ogdie, William J Taylor, Mark Weatherall, et al.
Clinical Rheumatology|April 25, 2014
New gout test: enhanced ex vivo cytokine production from PBMCS in common gout patients and a gout patient with Kearns-Sayre syndromeTim L Jansen, Dianne Berendsen, Tania O Crisan, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Clinical Rheumatology|June 15, 2016
Discrepancies in how the impact of gout is assessed in outcomes research compared to how health professionals view the impact of gout, using the lens of the International Classification of Functioning, Health and Disability (ICF)Eveline M Kool, Marieke J Nijsten, Annelies E van Ede, et al.
Deutsches Arzteblatt International|October 2, 2009
Gout--current diagnosis and treatmentAnne-Kathrin Tausche, Tim L Jansen, Hans-Egbert Schröder, et al.
Rheumatology (Oxford, England)|September 2, 2024
An objective diagnosis of gout and calcium pyrophosphate deposition disease with machine learning of Raman spectra acquired in a point-of-care settingTom Niessink, Tim L Jansen, Frank A W Coumans, et al.
The Lancet. Rheumatology|June 19, 2026
Gout treat-to-target for whom? - Authors' replyAnusha Moses, Martijn A H Oude Voshaar, Mart A F J van de Laar, et al.
Arthritis Care & Research|April 15, 2024
Diagnostic Accuracy of Raman Spectroscopy Integrated With Polarized Light Microscopy for Calcium Pyrophosphate-Associated ArthritisTom Niessink, Matthijs Janssen, Tanja Giesen, et al.
Expert Opinion on Drug Safety|March 16, 2011
The potential risk of infections during (prolonged) rituximab therapy in rheumatoid arthritisIthamar Heber Brinkman, Mart A F J van de Laar, Tim L Jansen, et al.
Rheumatology and Therapy|February 16, 2019
Reassessing the Safety Profile of Lesinurad in Combination with Xanthine Oxidase Inhibitor TherapyFernando Perez-Ruiz, Tim L Jansen, Anne-Kathrin Tausche, et al.
Annals of the Rheumatic Diseases|August 7, 2012
Gout: why is this curable disease so seldom cured?Michael Doherty, Tim L Jansen, George Nuki, et al.
Annals of the Rheumatic Diseases|June 12, 2014
Imaging modalities for the classification of gout: systematic literature review and meta-analysisAlexis Ogdie, William J Taylor, Mark Weatherall, et al.
Clinical Rheumatology|April 25, 2014
New gout test: enhanced ex vivo cytokine production from PBMCS in common gout patients and a gout patient with Kearns-Sayre syndromeTim L Jansen, Dianne Berendsen, Tania O Crisan, et al.
Pageof 9